| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.31 | 2e-10 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.18 | 0.0003 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.094 | 0.002 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.002 |